Results 251 to 260 of about 4,742,503 (345)

Hormonal interactions in endometrial cancer.

, 2000
Günter Emons, G. Fleckenstein, B. Hinney, A Huschmand, W. Heyl   +4 more
openalex   +1 more source

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews, Arron Lacey, Kate Bache, Emma J. Kidd   +3 more
wiley   +1 more source

Hormonal Contraception and Endometrial Thickness in IVF/ICSI Cycles: A Multicentre Historical Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To study the association between previous use of levonorgestrel intrauterine system (LNG‐IUS) and endometrial thickness (EMT) in women undergoing in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles. Design Multicentre historical cohort study.
Mette Peters Michaelsen, Laura Cæcilie Nielsen, Michelle Poulsen, Regitze Gyldenholm Skals, Bettina Troest, Janne Gasseholm Bentzen, Jimmi Elers, Anette Vestergaard Gabrielsen, Marie Louise Grøndahl, Betina Boel Povlsen, Mikael Tang‐Pedersen, Ulrik Schiøler Kesmodel   +11 more
wiley   +1 more source

AI-Augmented Advances in the Diagnostic Approaches to Endometrial Cancer. [PDF]

Cancers (Basel)
Ansari NM, Khalid U, Markov D, Bechev K, Aleksiev V, Markov G, Poryazova E.   +6 more
europepmc   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Cell‐Free and Concentrated Ascites Reinfusion Therapy (CART) Shows Enhanced Efficacy in Gynecological Cancer Patients: A Post‐Marketing Surveillance Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Ascites management is crucial for gynecological cancer patients requiring long‐term treatment. Cancer type‐specific differences may influence CART outcomes, but comparative data remain limited. This study evaluated CART efficacy in gynecological versus other cancers.
Nami Tamura, Takashi Hirayama, Emiko Yoshida, Junna Terao, Misato Kawata, Kengo Hiranuma, Toshiyuki Okumura, Kazunari Fujino, Naoko Torii, Noriko Soneda, Go Murayama, Makio Kusaoi, Ken Yamaji, Yasuhisa Terao   +13 more
wiley   +1 more source

Serum biomarkers and clinicopathologic postoperative prognostic factors for in endometrial cancer patients. [PDF]

Am J Transl Res
Gao H, Xiao M, Feng Y, Zhang J.
europepmc   +1 more source

Development and Real‐World Evaluation of a Statewide Mainstream Model of Germline Genetic Testing for BRCA1/2 and Mismatch Repair Gene Variants (Lynch Syndrome)

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This translational quality improvement study evaluated a statewide pathway for mainstream genetic testing in South Australia. Adoption of mainstream BRCA1/2 testing increased significantly, but not MMR testing. Findings highlight the need for tailored, context‐specific strategies to integrate genetic testing into routine care across diverse cancer ...
Cally A. Jennings, Kathryn Cornthwaite, Michael Osborn, Ganessan Kichenadasse, Eryn Dow   +4 more
wiley   +1 more source